Prediction of Cancer Incidence and Mortality in Korea, 2022
- PMID: 35313101
- PMCID: PMC9016306
- DOI: 10.4143/crt.2022.179
Prediction of Cancer Incidence and Mortality in Korea, 2022
Abstract
Purpose: This study aimed to report the projected cancer incidence and mortality for the year 2022 to estimate Korea's current cancer burden.
Materials and methods: Cancer incidence data from 1999 to 2019 were obtained from the Korea National Cancer Incidence Database, and cancer mortality data from 1993 to 2020 were acquired from Statistics Korea. Cancer incidence and mortality were projected by fitting a linear regression model to observed age-specific cancer rates against their respective years and then by multiplying the projected age-specific rates by the anticipated age-specific population for 2022. A joinpoint regression model was used to determine the year in which the linear trend changed significantly; we only used the data of the latest trend.
Results: In total, 274,488 new cancer cases and 81,277 cancer deaths are expected to occur in Korea in 2022. The most common cancer site is expected to be the thyroid, followed by the lung, colon and rectum, breast, and stomach. These five cancers are expected to represent half of the overall burden of cancer in Korea. The most common type of cancer leading to death is expected to be lung cancer, followed by liver, colorectal, pancreatic, and gallbladder cancers.
Conclusion: The incidence rates for all types of cancer in Korea are estimated to gradually decrease. These up-to-date estimates of the cancer burden in Korea could be an important resource for planning and evaluating cancer-control programs.
Keywords: 2022; Forecasting; Incidence; Korea; Mortality; Neoplasms.
Conflict of interest statement
Conflict of interest relevant to this article was not reported.
Figures



Similar articles
-
Prediction of Cancer Incidence and Mortality in Korea, 2023.Cancer Res Treat. 2023 Apr;55(2):400-407. doi: 10.4143/crt.2023.448. Cancer Res Treat. 2023. PMID: 36915244 Free PMC article.
-
Prediction of Cancer Incidence and Mortality in Korea, 2024.Cancer Res Treat. 2024 Apr;56(2):372-379. doi: 10.4143/crt.2024.252. Epub 2024 Mar 11. Cancer Res Treat. 2024. PMID: 38487833 Free PMC article.
-
Prediction of Cancer Incidence and Mortality in Korea, 2021.Cancer Res Treat. 2021 Apr;53(2):316-322. doi: 10.4143/crt.2021.290. Epub 2021 Mar 17. Cancer Res Treat. 2021. PMID: 33735558 Free PMC article.
-
Cancer statistics, 2004.CA Cancer J Clin. 2004 Jan-Feb;54(1):8-29. doi: 10.3322/canjclin.54.1.8. CA Cancer J Clin. 2004. PMID: 14974761 Review.
-
Challenges and Suggestions in Management of Lung and Liver Cancer in Uzbekistan: The Second Report of the Uzbekistan-Korea Oncology Consortium.Int J Environ Res Public Health. 2022 Sep 17;19(18):11727. doi: 10.3390/ijerph191811727. Int J Environ Res Public Health. 2022. PMID: 36142000 Free PMC article. Review.
Cited by
-
Re-Increasing Trends in Thyroid Cancer Incidence after a Short Period of Decrease in Korea: Reigniting the Debate on Ultrasound Screening.Endocrinol Metab (Seoul). 2022 Oct;37(5):816-818. doi: 10.3803/EnM.2022.1586. Epub 2022 Oct 11. Endocrinol Metab (Seoul). 2022. PMID: 36220136 Free PMC article. No abstract available.
-
Combination of oxaliplatin and β-carotene suppresses colorectal cancer by regulating cell cycle, apoptosis, and cancer stemness in vitro.Nutr Res Pract. 2024 Feb;18(1):62-77. doi: 10.4162/nrp.2024.18.1.62. Epub 2023 Dec 26. Nutr Res Pract. 2024. PMID: 38352212 Free PMC article.
-
Where do we stand?-Recent update of shock wave therapy as penile rehabilitation for postprostatectomy erectile dysfunction.Transl Androl Urol. 2023 Feb 28;12(2):158-160. doi: 10.21037/tau-23-33. Epub 2023 Feb 20. Transl Androl Urol. 2023. PMID: 36915874 Free PMC article. No abstract available.
-
Robot-assisted versus conventional laparoscopic radical hysterectomy in cervical cancer stage IB1.Int J Med Sci. 2023 Jan 22;20(3):287-291. doi: 10.7150/ijms.79830. eCollection 2023. Int J Med Sci. 2023. PMID: 36860680 Free PMC article.
-
Clinicopathological and molecular features of genome-stable colorectal cancers.Histol Histopathol. 2025 Mar;40(3):381-388. doi: 10.14670/HH-18-785. Epub 2024 Jun 25. Histol Histopathol. 2025. PMID: 38993017
References
-
- Statistics Korea [Internet] Daejeon: Statistics Korea; 2022. [cited 2022 Mar 8]. Available from: http://kosis.kr .
-
- Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, et al. International classification of diseases for oncology. 3rd ed 1st rev. Geneva: World Health Organization; 2013.
-
- World Health Organization . International statistical classification of diseases and related health problems. 10th rev. Geneva: World Health Organization; 1994.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical